Literature DB >> 10652212

Effect of interleukin-1beta on aromatase activity and cell proliferation in human osteoblast-like cells (HOS).

M Morioka1, K Shimodaira, Y Kuwano, H Fujikawa, H Saito, T Yanaihara.   

Abstract

Osteoblast cells have a capacity to produce estrogen from androgen. It is known that inflammatory cytokines in bone increase during estrogen deficiency. In the present study, the effect of interleukin-1beta (IL-1beta) on aromatase (Arom) activity in human osteoblast-like cells (HOS) was investigated. We also investigated the effect of IL-1beta and estradiol (E2) on cell proliferation in HOS. [(3)H] water method was employed to measure Arom activity. Expression of Arom mRNA was determined by the reverse-transcription polymerase chain reaction (RT-PCR) method. The PCR products were confirmed by Southern blot analysis. Cell proliferation was measured by an ELISA-bromo deoxyuridine (BrdU) kit. Addition of IL-1beta increased Arom activity in a dose-dependent manner and addition of IL-1beta (10 ng/ml) resulted in 40% greater activity than control. Addition of 500 ng/ml of human recombinant IL-1 receptor antagonist neutralized the increased Arom activity to control level. Stimulation of Arom mRNA expression by IL-1beta was also found. IL-1beta and E2 stimulate osteoblastic cell proliferation significantly. These findings suggest for the first time that IL-1beta stimulates Arom activity through the IL-1 receptor and also cell proliferation in osteoblast-like cells. It is also demonstrated that this stimulatory effect may be through the IL-1 receptor. Cell proliferation stimulated by IL-1beta was reduced by the addition of the Arom inhibitor fadrozole-HCL (CGS-16949A). These results imply that IL-1beta has a stimulatory effect on estrogen formation and sequentially cell proliferation in bone, and this mechanism may play an important role in osteoblastic function especially in postmenopausal women. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10652212     DOI: 10.1006/bbrc.1999.2063

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  The gene for aromatase, a rate-limiting enzyme for local estrogen biosynthesis, is a downstream target gene of Runx2 in skeletal tissues.

Authors:  Jae-Hwan Jeong; Youn-Kwan Jung; Hyo-Jin Kim; Jung-Sook Jin; Hyun-Nam Kim; Sang-Min Kang; Shin-Yoon Kim; Andre J van Wijnen; Janet L Stein; Jane B Lian; Gary S Stein; Shigeaki Kato; Je-Yong Choi
Journal:  Mol Cell Biol       Date:  2010-03-15       Impact factor: 4.272

2.  Noise-induced hearing loss: Neuropathic pain via Ntrk1 signaling.

Authors:  Senthilvelan Manohar; Kimberly Dahar; Henry J Adler; Ding Dalian; Richard Salvi
Journal:  Mol Cell Neurosci       Date:  2016-07-26       Impact factor: 4.314

3.  Interleukin 1β and tumor necrosis factor α promote hFOB1.19 cell viability via activating AP1.

Authors:  Hongliang Ying; Qiang Li; Changfu Zhao
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

4.  Neuroinflammation induces glial aromatase expression in the uninjured songbird brain.

Authors:  Kelli A Duncan; Colin J Saldanha
Journal:  J Neuroinflammation       Date:  2011-07-18       Impact factor: 8.322

5.  Roles of Aryl Hydrocarbon Receptor in Aromatase-Dependent Cell Proliferation in Human Osteoblasts.

Authors:  Yasuhiro Miki; Shuko Hata; Katsuhiko Ono; Takashi Suzuki; Kiyoshi Ito; Hiroyuki Kumamoto; Hironobu Sasano
Journal:  Int J Mol Sci       Date:  2017-10-17       Impact factor: 5.923

Review 6.  Central aromatization: A dramatic and responsive defense against threat and trauma to the vertebrate brain.

Authors:  Kelli A Duncan; Colin J Saldanha
Journal:  Front Neuroendocrinol       Date:  2019-11-28       Impact factor: 8.333

7.  Duffy antigen receptor for chemokines regulates post-fracture inflammation.

Authors:  Charles H Rundle; Subburaman Mohan; Bouchra Edderkaoui
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.